Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab-MedSci.cn

Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab

Leipe, J; Wilke, EL; Ebert, MP; Teufel, A; Reindl, W

Leipe, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Div Rheumatol,Dept Med 5, Heidelberg, Germany.